SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (8902)3/2/1999 12:48:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Dr. Opal will be presenting as will Scannon. (Scannon will be their but don't know if he presents) Have not finished looking at Final Program.

ulb.ac.be

ulb.ac.be

Wed. 9.45
BPI in meningococcemia and hemorrhagic
trauma
WJ Scannon (Berkeley, USA)



To: opalapril who wrote (8902)3/3/1999 11:44:00 AM
From: aknahow  Read Replies (1) | Respond to of 17367
 
So, Dr. Scannon presents in Belgium. I expect to have XOMA provide shareholders with an on line abstract of what he says. Xoma has been a bit sticky about providing releases by Scannon. They may say it is only a clinical update and has nothing new. In which case I will again wonder why spend the money sending someone abroad to present something that is not novel.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News